Quipt Home Medical Corp 2023年度报告

QUIPT HOME MEDICAL CORP. (Exact name of registrant as specified in its charter) Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act. Yes ˄ No ˄ Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during thepreceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past90 days. Yes ˄ No ˄ Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T(§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ˄ No ˄ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerginggrowth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 ofthe Exchange Act. If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revisedfinancial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ˄ Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control overfinancial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its auditreport. Yes ˄ No ˄ If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflectthe correction of an error to previously issued financial statements. ˄ Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any ofthe registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). ˄ Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ˄ No ˄ The aggregate market value of the voting and non-votingcommon shares held by non-affiliates of the registrant computed as of March 28, 2024 (the last businessday of the registrant’s most recently completed second fiscal quarter) based on the closing price of the registrant’s common shares on the Nasdaq Capital Market was$153,207,393. There were 43,091,273 common shares of the registrant outstanding as of December 11, 2024. Documents Incorporated by Reference Portions of the Proxy Statement for the 2025 Annual Meeting of Shareholders, which will be filed within one hundred and twenty days of the fiscal year endedSeptember 30, 2024 (2025 Proxy Statement), are incorporated by reference into Part III of this report to the extent described herein. FORM 10-K TABLE OF CONTENTS PART IItem 1.Business6Item 1A.Risk Factors8Item 1B.Unresolved Staff Comments31Item 1C.Cybersecurity31Item 2.Properties32Item 3.Legal Proceedings33Item 4.Mine Safety Disclosure33PART IIItem 5.Market for Registrant’s Common Equity, Related Shareholder Matters and IssuerPurchases of Equity Securities34Item 6.[Reserved]34Item 7.Management’s Discussion and Analysis of Financial Condition and Results ofOperations35Item 7A.Quantitative and Qualitative Disclosures about Market Risk51Item 8.Financial Statements and Supplementary Data53Item 9.Changes in and Disagreements with Accountants on Accounting and FinancialDisclosure83Item 9A.Controls and Procedures83Item 9B.Other Information84Item 9C.Disclosure Regarding Foreign Jurisdictions that Prevent Inspections84PART IIIItem 10.Directors, Executive Officers and Corporate Governance85Item 11.Executive Compensation85Item 12.Security Ownership of Certain Beneficial Owners and Management and RelatedShareholder Matters85Item 13.Certain Relationships and Related Transactions and Director Independence85Item 14.Principal Accountant Fees and Services85PART IVItem 15.Exhibits and Financial Statement Schedules86Item 16.Form 10-K Summary88Signatures89 CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS This Annual Report on Form 10-K, including Management’s Discussion and Analysis (“MD&A”) in Item 7,contains certain “forward-looking information” within the meaning of Canadian securities legislation and “forward-looking statements” within the meaning of applicable securities legislation, including the US Private SecuritiesLitigation Reform Act of 1995 (collectively, “forward-looking statements”). Forward-looking statements are neitherhistorical facts nor assurances of future performan